BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide
A 120mg combination blend 100mg NAD+, 10mg MOTS-c, and 10mg 5-Amino-1MQ
Key Takeaways BPC-157 is a synthetic peptide, made up of fifteen amino acids This peptide is studied in the laboratory and medical literature Researchers investigate it for its stability, cellular signaling activity, and the part it plays in experimental tissue and gastrointestinal biology The majority of published evidence comes from in vitro and animal studies BPC-157 isnt FDA-approved as a therapeutic drug, although its regulatory status continues to evolve as additional evidence is evaluated
Rare but serious risks, especially with higher doses or certain risk factors, include blood clots, stroke, and elevated blood pressure
Pharmacologically, KLOW is mostly given as small subcutaneous injections in research studies, with typical vials containing 50 to 100 milligrams, split into daily or every-other-day doses over 410 week cycles
Retatrutide is an investigational medication that hasnt been approved by the MHRA
